arrow
T

T.W. Kim

Konyang University Hospital
H指数:10
被引数:544

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Assessing the Efficacy of Ligilactobacillus salivarius CLS0420 and Lacticaseibacillus paracasei CLPC0603 on Vaginal Well-Being in Healthy Women: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial

更正:评估Ligilactobacillus salivarius CLS0420和Lacticaseibacillus paracasei CLPC0603对健康女性阴道健康的影响:一项初步的、随机、双盲、安慰剂对照试验

2025-07-310
PREAI
Assessing the Efficacy of Ligilactobacillus salivarius CLS0420 and Lacticaseibacillus paracasei CLPC0603 on Vaginal Well-Being in Healthy Women: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial

评估唾液乳杆菌Ligilactobacillus salivarius CLS0420和副干酪乳杆菌Lacticaseibacillus paracasei CLPC0603对健康女性阴道健康的影响:一项探索性、随机、双盲、安慰剂对照试验

2025-04-070
PRE
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer

妇科癌症2023年的主要临床研究进展: 子宫内膜癌动荡的一年

2024-01-012
OAAI
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

泛亚适应ESMO临床实践指南,用于转移性乳腺癌患者的诊断,分期和治疗

2023-06-0119
OAAI
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

针对头颈部鳞状细胞癌患者的诊断,治疗和随访的ehns-esmo-estro临床实践指南的泛亚适应

2021-12-0138
OAAI
Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study
2020-11-010
OAAI
Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
2020-09-018
OAAI
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
2019-01-0148
OAAI